GENEVA (UrduPoint News / Sputnik – 05th July, 2020) The World Health Organization (WHO) announced on Saturday that it was discontinuing the trials of hydroxychloroquine and combination lopinavir/ritonavir treatment as part of its tests to find efficient remedies against COVID-19.
“WHO today accepted the recommendation from the Solidarity Trial’s International Steering Committee to discontinue the trial’s hydroxychloroquine and lopinavir/ritonavir arms.
The Solidarity Trial was established by WHO to find an effective COVID-19 treatment for hospitalized patients,” the organization said in a statement.
Remdesivir, hydroxychloroquine and lopinavir/ritonavir were tested in the first Solidarity Trial, which WHO has been conducting since March. The trials involved more than 4,500 patients.